Changes in nutritional status in hepatocellular carcinoma patients treated with sorafenib
The loss in fat and muscle mass in patients undergoing sorafenib therapy for HCC was associated with poorer PFS and OS.
Authors
- Marta Stelmach-Mardas
- Maria Litwiniuk (ORCID: https://orcid.org/0000-0001-8428-3877)
- Marcin Mardas (ORCID: https://orcid.org/0000-0002-5518-6143)
- Piotr Radomyski (ORCID: https://orcid.org/0000-0003-0062-1125)
- Radosław Osmański
Institutions
- Poznan University of Medical Sciences (PL)
- Greater Poland Cancer Center (PL)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1007/s00520-025-09975-9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00